Events for February 8, 2026 – SOHO Insider

Skip to content

FDA approves revumenib in relapsed or refractory NMP1-mutated AML
FDA approves blenrep combo in relapsed or refractory MM
FDA grants orphan drug designation to MDS investigational therapy ofirnoflast
Despite digital advances, cancer research remains costly, burdensome
Bexmarilimab continues to show strong efficacy in phase 1/2 trial update

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Cellular Therapy

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Leukemia

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Lymphoma

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Multiple Myeloma

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Myelodysplastic Syndromes

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

October 26, 2025

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

SOHO Insider Events

1 event found.

Events Search and Views Navigation

Enter Keyword. Search for Events by Keyword.

Event Views Navigation

List
Month
Day

Select date.

All Day

February 4, 2026 - February 8, 2026

Tandem Meetings 2026

Salt Palace Convention Center 100 S W Temple St, Salt Lake City

Previous Day
Next Day

Google Calendar
iCalendar
Outlook 365
Outlook Live
Export .ics file
Export Outlook .ics file

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Cellular Therapy

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Leukemia

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Lymphoma

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Multiple Myeloma

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Myelodysplastic Syndromes

IMS Practical Insights in and Translational Aspects of Novel Immune Therapies in Multiple Myeloma

Myeloproliferative Neoplasms

Subscribe

Recent Posts

FDA approves revumenib in relapsed or refractory NMP1-mutated AML

FDA approved

FDA approves blenrep combo in relapsed or refractory MM

FDA editorial

FDA grants orphan drug designation to MDS investigational therapy ofirnoflast

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.